SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-081778
Filing Date
2020-07-07
Accepted
2020-07-07 17:27:42
Documents
8
Period of Report
2020-07-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2024283-1_8k.htm 8-K 65183
2 EXHIBIT 10.1 tm2024283d1_ex10-1.htm EX-10.1 207325
3 EXHIBIT 99.1 tm2024283d1_ex99-1.htm EX-99.1 417427
4 EXHIBIT 99.2 tm2024283d1_ex99-2.htm EX-99.2 1100022
5 EXHIBIT 99.3 tm2024283d1_ex99-3.htm EX-99.3 10601
6 EXHIBIT 99.4 tm2024283d1_ex99-4.htm EX-99.4 33610
7 GRAPHIC tm2024283d1_ex99-2img001.jpg GRAPHIC 159549
8 GRAPHIC tm2024283d1_ex99-4img01.jpg GRAPHIC 2107
  Complete submission text file 0001104659-20-081778.txt   2058649
Mailing Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008
Business Address 900 E. HAMILTON AVENUE SUITE 550 CAMPBELL CA 95008 6509345200
VIVUS INC (Filer) CIK: 0000881524 (see all company filings)

IRS No.: 943136179 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33389 | Film No.: 201016720
SIC: 2834 Pharmaceutical Preparations